In conclusion, these findings collectively demonstrate that GPR65 on TAMs serves as the key sensor for lactate signaling in the tumor microenvironment, driving the malignant progression and mesenchymal transition of glioma cells. The gene discussed is GPR65; the disease is central nervous system cancer.